Sevelamer restores bone volume and improves bone microarchitecture and strength in aged ovariectomized rats

Endocrinology

Volumn 149, Issue 12, 2008, Pages 6092-6102

  Sampath, T Kuber ^a   Simic, Petra ^b   Moreno, Sarah ^a   Bukanov, Nikolay ^a   Draca, Natasa ^b   Kufner, Vera ^b   Tikvica, Ana ^b   Blair, Andrew ^a   Semenski, Damir ^c   Brncic, Mladen ^d   Burke, Steven K ^e   Vukicevic, Slobodan ^b  

^a GENZYME CORPORATION   (United States)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

^e Proteon Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN; FIBROBLAST GROWTH FACTOR 23; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAGNESIUM; OSTEOCALCIN; PHOSPHATE; SEVELAMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE STRENGTH; BONE STRUCTURE; CELL CULTURE; CELL DIFFERENTIATION; COMPUTER ASSISTED TOMOGRAPHY; MESENCHYMAL STEM CELL; MORPHOMETRICS; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; RAT; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; OSTEOBLASTS; OSTEOCLASTS; OVARIECTOMY; POLYAMINES; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; X-RAY MICROTOMOGRAPHY;

EID: 57349198737     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0205     Document Type: Article

References (49)

1. London GM, Guerin AP, Marchais SJ, Métivier F, Pannier B, Adda H 2003 Arterial media calcification in end stage renal disease: impact on all cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731-1740
2. Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, Steffes MW, Toto R 2003 Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 42:617-622
3. Ribeiro S, Ramos A, Brandao A, Rebelo JR, Guerra A, Resina C, Vila-Lobos A, Carvalho F, Remédio F, Ribeiro F 1998 Cardiac valve calcification in haemodialysis patients. Role of calcium phosphate metabolism. Nephrol Dial Transplant 13:2037-2040
4. Raggi P, James G, Burke SK, Bommer J, Chasan-Taber S, Holzer H, Braun J, Chertow GM 2005 Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. J Bone Miner Res 20:764 -772
5. Chertow GM, Burke SK, Raggi P 2002 Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252
6. Heaney RP 2004 Phosphorus nutrition and the treatment of osteoporosis. Mayo Clin Proc 79:91-97
7. Slatopolsky EA, Burke SK, Dillon MA 1999 RenaGel, a nonabsorbed calcium-and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group. Kidney Int 55:299-307
8. Chertow GM, Raggi P, McCarthy JT, Schulman G, Silberzweig J, Kuhlik A, Goodman WG, Boulay A, Burke SK, Toto RD 2003 The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients. Am J Nephrol 23:307-314
9. Kincaid SA, Lauten SD, Wright JC 2002 In vivo whole body and appendicular bone mineral density in rats: a dual energy X-ray absorptiometry study. Comp Med 52:143-51
10. Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD 1993 Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Endocrinology 136:2435-2441
11. Jamsa T, Jalovaara P, Peng Z Vaananen HK, Tuukkanen J 1998 Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia. Bone 23:155-161
12. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C 1999 Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERβ-/- mice. J Clin Invest 104:895-901
13. Ruegsegger P, Koller B, Mullar R 1996 A microtomographic system for the non-destructive evaluation of bone architecture. Calcif Tissue Int 58:24-29
14. Ito M, Nakamura T, Matsumoto T, Tsurusaki K, Hayashi K 1998 Analysis of trabecular microarchitecture of human iliac bone using micro-computed tomography in patients with a hip arthrosis with or without vertebral fracture. Bone 23:163-169
15. Hildebrand T, Laib A, Muller R, Dequeker J, Rüegsegger P 1999 Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneous. J Bone Miner Res 14:1167-1174
16. Hahn M, Vogel M, Pompesious-Kempa M, Delling G 1992 Trabecular bone pattern factor - a new parameter for simple quantification of bone microarchitecture. Bone 13:327-330
17. Hildebrand T, Ruegsegger P 1997 Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Engin 1:15-23
18. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols and units. J Bone Miner Res 2:595-610
19. Krempien B, Vukicevic S, Vogel, Stavljenic A, Buchele R 1988 Cellular basis of inflammation-induced osteopenia in growing rats. J Bone Miner Res 3:573-582
20. Vukicevic S, Krempien B, Stavljenic A 1987 Effects of 1 α,25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats. J Bone Miner Res 2:533-545
21. Turner CH, Burr DB 1993 Basic biomechanical measurements of bone: a tutorial. Bone 14:595-608
22. Meng XW, Liang XG, Birchman R, Wu DD, Dempster DW, Lindsay R, Shen V 1996 Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J Bone Miner Res 11:421-429
23. Shen V, Birchman R, Xu R, Otter M, Wu D, Lindsay R, Dempster DW 1995 Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats. J Clin Invest 96:2331-2338
24. Buckbinder L, Crawford DT, Qi H, Ke HZ, Olson LM, Long KR, Bonnette PC, Baumann AP, Hambor JE, Grasser 3rd WA, Pan LC, Owen TA, Luzzio MJ, Hulford CA, Gerhard DF, Paralkar VM, Simmons HA, Kath JC, Roberts WG, Smock SL, Guzman-Perez A, Brown TA, Li M 2007 Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis. Proc Natl Acad Sci USA 104:10619-10624
25. Kitaura H, Sands MS, Aya K, Zhou P, Hirayama T, Uthgenannt B, Wei S, Takeshita S, Novack DV, Silva MJ, Abu-Amer Y, Ross FP, Teitelbaum SL 2004 Marrow stromal cells and osteoclast precursors differentially contribute to TNF-α-induced osteoclastogenesis in vivo. J Immunol 173:4838-4846
26. Purohit S, Podolsky R, Schatz D, Muir A, Hopkins D, Huang YH, She JX 2006 Assessing the utility of SELDI-TOF and model averaging for serum proteomic biomarker discovery. Proteomics 6:6405-6415
27. Poon TC 2007 Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev Proteomics 4:51-65
28. Block GA, Raggi P, Bellasi, Kooienga L, Spiegel DM 2007 Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71:438-441
29. Iwata Y, Wada T, Yokoyama H, Toyama T, Kitajima S, Okumura T, Hara A, Yamahana J, Nakaya I, Kobayashi M, Kitagawa K, Kokubo S, Yoshimoto K, Shimizu K, Sakai N, Furuichi K, Koshino Y, Takeda S, Takasawa K, Ohta S, Takaeda M, Takaeda C, Kaneko S 2007 Effect of sevelamer hydrochloride on markers of bone turnover in Japanese dialysis patients with low biointact PTH levels. Intern Med 46:447-452
30. Ferreira A, Frazao JM, Monier-Faugere MC, Gil C, Galvao J, Oliveira C, Baldaia J, Rodrigues I, Santos C, Ribeiro S, Hoenger RM, Duggal A, Malluche HH, Sevelamer Study Group 2008 Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol 19:405-412
31. Mathew S, Lund RJ, Strebeck F, Tustison KS, Geurs T, Hruska KA 2007 Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol 8:122-130
32. Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311
33. Karsenty G, Wagner EF 2002 Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406
34. Rodan GA, Martin TJ 1981 Role of osteoblasts in hormonal control of bone resorption: a hypothesis. Calcif Tissue Int 33:349-351
35. Teitelbaum SL 2000 Bone resorption by osteocalsts. Science 289:1504-1508
36. Bone HG 2004 Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189-1199
37. Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR 1995 Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 122:9-16 V 1996 Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J Bone Miner Res 11:421-429
38. Rico H, Relea P, Revilla M, Hernandez ER, Arribas I, Villa LF 1993 Biochemical markers of nutrition in osteoporosis. Calcif Tissue Int 52:331-333
39. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434 -1441
40. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT 2003 Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841-846
41. Tashjian Jr AH, Gagel RF 2006 Teriparatide [Human PTH (1-34)]: 2.5 years of experience on the use of safety of the drug for the treatment of osteoporosis. J Bone Mine Res 21:354-365
42. Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S 2007 Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. J Bone Miner Res 22:849-859
43. Simic P, Culej JB, Orlic I, Grgurevic L, Draca N, Spaventi R, Vukicevic S 2006 Systemically administered bone morphogenetic protein-6 restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption. J Biol Chem 281:25509-25521
44. Sun L, Vukicevic S, Baliram R, Yang G, Sendak R, McPherson J, Zhu LL, Iqbal J, Latif R, Natrajan A, Arabi A, Yamoah K, Moonga BS, Gabet Y, Davies TF, Bab I, Abe E, Sampath K, Zaidi M 2008 Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proc Natl Acad Sci USA 105:4289-94
45. Othmane Tel H, Bakonyi G, Egresits J, Fekete BC, Fodor E, Jarai Z, Jekkel C, Nemcsik J, Szabo A, Szabo T, Kiss I, Tisler A 2007 Effect of sevelamer on aortic pulse wave velocity in patients on hemodialysis: a prospective observational study. Hemodial Int 11(Suppl 3):S13-S21
46. Frohlander N, Ljunggren O, Lerner UH 1991 Haptoglobin synergistically potentiates bradykinin and thrombin induced prostaglandin biosynthesis in isolated osteoblasts. Biochem Biophys Res Commun 178:343-351
47. Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A 2003 Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 88:1523-1527
48. Yalin S, Bagis S, Polat G, Dogruer N, Cenk Aksit S, Hatungil R, Erdogan C 2005 Is there a role of free oxygen radicals in primary male osteoporosis? Clin Exp Rheumatol 23:689-692
49. Moreno-Reyes R, Egrise D, Neve J, Pasteels JL, Schoutens A 2001 Selenium deficiency-induced growth retardation is associated with an impaired bone metabolism and osteopenia. J Bone Miner Res 16:1556-1563